ARRS: Disease Mortality Risk Trumps Radiation Risk

Share this content:
ARRS: Disease Mortality Risk Trumps Radiation Risk
ARRS: Disease Mortality Risk Trumps Radiation Risk

(HealthDay News) – For young adults, the risk of short-term mortality from inherent disease is larger than the predicted risk of computed-tomography (CT)-induced cancer, across all CT scanning frequencies, according to a study presented at the annual meeting of the American Roentgen Ray Society, held from April 29 to May 4 in Vancouver, Canada.

Rob Zondervan, from Massachusetts General Hospital in Boston, and colleagues investigated the scanning frequency, patient outcome, and predicted cancer incidence for 8,133 patients aged 18 to 35 years patients who underwent chest CT and 15,226 who underwent abdomino-pelvic CT, from 2003 to 2007. The frequency of CT scanning was classified as very rare (1 to 2), rare (2 to 5), moderate (6 to 15), and frequent (more than 15).

The researchers found that, after a mean of 4.2 years, 5% of very rarely, 14% of rarely, 22% of moderately, and 50% of frequently scanned patients in the chest CT cohort died. The predicted number of radiation-induced cancers in each scanning category was 6, 2, 3, and 1 case, respectively, corresponding to cancer incidences of 0.08, 0.22, 0.52, and 1.13%. After a mean follow-up of 3.5 years, the corresponding proportions of deceased patients in the abdomen CT cohort were 2, 10, 17, and 33%. The predicted number of radiation-induced cancers was 14, 4, 4, and 1, respectively, corresponding to cancer incidences of 0.1, 0.27, 0.65, and 1.40%, respectively.

"A majority of cancers are predicted to occur in the very rarely scanned. However, across all scanning frequencies, the risk of short-term mortality from inherent disease is far larger than the predicted risk of cancer induced by CT," the authors write.

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs